Explore 3 Stock Ideas & Industry Insights Download Free Report

McKesson Corporation

Company price
1034.835 USD 35.22 ( 3.52%)
Last update at 2026-11-04T18:27:00Z
VOLUME
268303
Market Cap
104880.02M
P/E
24.45

Momentum Score

…

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1004.88
Low
1038.90
High
52 Week Price Range
684.98
Low
996.84
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
999.62
Dividend Yield
0.36%
Revenue TTM
410983.01M
Revenue Per Share
3367.33
Gross Profit TTM
14933.00M
Debt / Equity
-3.97
ROE
-
Net Debt
4639.00M
ROCE
42.13%
Diluted EPS TTM
36.79

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax 6201.00M 4359.00M 3789.00M 4630.00M 1928.00M
Minority interest -337.00M -186.00M -158.00M 162.00M -173.00M
Net income 4762.00M 3295.00M 3002.00M 3560.00M 1114.00M
Selling general administrative 8096.00M 8507.00M 6910.00M 15552.00M 21074.00M
Selling and marketing expenses 8096.00M - 1100.00M -7776.00M -10537.00M
Gross profit 14550.00M 12485.00M 12202.00M 12358.00M 13130.00M
Reconciled depreciation 729.00M 636.00M 635.00M 608.00M 760.00M
Ebit 6448.00M 4615.00M 4032.00M 4381.00M 2852.00M
Ebitda 7177.00M 5251.00M 4667.00M 5687.00M 3612.00M
Depreciation and amortization 729.00M 636.00M 635.00M 1306.00M 760.00M
Non operating income net other - - - 497.00M 68.00M
Operating income 6454.00M 4372.00M 3927.00M 4381.00M 2852.00M
Other operating expenses 396976.00M 354679.00M 305024.00M 272129.00M 261373.00M
Interest expense 247.00M 256.00M 243.00M 248.00M 178.00M
Tax provision 1102.00M 878.00M 629.00M 905.00M 636.00M
Interest income 179.00M 173.00M 118.00M 248.00M 10.00M
Net interest income -68.00M -92.00M -134.00M -248.00M -178.00M
Extraordinary items - 0.00M 0.00M -3.00M -5.00M
Non recurring - - - -8.00M 274.00M
Income tax expense 1102.00M 878.00M 629.00M 905.00M 636.00M
Total revenue 403430.00M 359051.00M 308951.00M 276711.00M 263966.00M
Total operating expenses 8096.00M 8113.00M 8275.00M 7776.00M 10537.00M
Cost of revenue 388880.00M 346566.00M 296749.00M 264353.00M 250836.00M
Total other income expense net -253.00M -13.00M -138.00M 249.00M -924.00M
Discontinued operations - - - -3.00M -5.00M
Net income from continuing ops 5099.00M 3481.00M 3160.00M 3725.00M 1292.00M
Net income applicable to common shares - 3295.00M 3002.00M 3560.00M 1114.00M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 82323.00M 75140.00M 67443.00M 62320.00M 63298.00M
Intangible assets 4079.00M 1464.00M 2110.00M 2277.00M 2059.00M
Other current assets 1043.00M 1063.00M 626.00M 496.00M 5414.00M
Total liab 83157.00M 76834.00M 69042.00M 63810.00M 65090.00M
Total stockholder equity -2172.00M -1694.00M -1599.00M -1857.00M -2272.00M
Deferred long term liab - - - 1387.00M 1418.00M
Other current liab 5490.00M 4825.00M 4915.00M 4200.00M 9284.00M
Common stock 3.00M 3.00M 3.00M 3.00M 2.00M
Capital stock 3.00M 3.00M 3.00M 3.00M 2.00M
Retained earnings 22291.00M 17921.00M 14978.00M 12295.00M 9030.00M
Other liab - - - 9808.00M 10142.00M
Good will 11316.00M 10022.00M 10132.00M 9947.00M 9451.00M
Other assets - 3869.00M 2946.00M 1755.00M 1251.00M
Cash 3975.00M 5691.00M 4583.00M 4678.00M 3532.00M
Cash and equivalents - 5691.00M 4583.00M 4678.00M 3532.00M
Total current liabilities 67017.00M 61604.00M 52357.00M 47957.00M 48466.00M
Current deferred revenue - - 1.00M - -
Net debt 4639.00M 1699.00M 2807.00M 2617.00M 4010.00M
Short term debt 1554.00M 1449.00M 345.00M 1267.00M 1096.00M
Short long term debt 1267.00M 1191.00M 50.00M 968.00M 799.00M
Short long term debt total 8614.00M 7390.00M 7390.00M 7295.00M 7542.00M
Other stockholder equity -23013.00M -19066.00M -16071.00M -13250.00M -9770.00M
Property plant equipment - 4284.00M 4045.00M 2177.00M 2092.00M
Total current assets 57210.00M 55398.00M 47970.00M 44292.00M 46231.00M
Net tangible assets - - - -12679.00M -12416.00M
Net receivables 27985.00M 25643.00M 21622.00M 19410.00M 18583.00M
Long term debt 5259.00M 4463.00M 5579.00M 4626.00M 5080.00M
Inventory 24207.00M 23001.00M 21139.00M 19691.00M 18702.00M
Accounts payable 59973.00M 55330.00M 47097.00M 42490.00M 38086.00M
Noncontrolling interest in consolidated entity - - - 367.00M 480.00M
Accumulated other comprehensive income -1453.00M -932.00M -881.00M -905.00M -1534.00M
Common stock total equity - - - 3.00M 2.00M
Retained earnings total equity - - - 12295.00M 9030.00M
Treasury stock - - - - -17045.00M
Non currrent assets other 4725.00M 3972.00M 2838.00M 1992.00M 1917.00M
Non current assets total 25113.00M 19742.00M 19473.00M 18028.00M 17067.00M
Capital lease obligations 2088.00M 1736.00M 1761.00M 1701.00M 1663.00M
Long term debt total - 5941.00M 7045.00M 4626.00M 5080.00M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments - -733.00M -1072.00M -542.00M -89.00M
Change to liabilities - - - 4151.00M 3045.00M
Total cashflows from investing activities -3432.00M -733.00M -1072.00M -542.00M -89.00M
Net borrowings 783.00M -21.00M 56.00M -277.00M -1334.00M
Total cash from financing activities -4631.00M -3965.00M -3342.00M -4368.00M -6321.00M
Change to operating activities - - - -1370.00M 49.00M
Net income 4762.00M 3481.00M 3160.00M 3722.00M 1287.00M
Change in cash -1981.00M 1371.00M -94.00M 743.00M -2461.00M
Begin period cash flow 5956.00M 4585.00M 4679.00M 3935.00M 6396.00M
End period cash flow 3975.00M 5956.00M 4583.00M 4678.00M 3935.00M
Total cash from operating activities 6155.00M 6085.00M 4314.00M 5159.00M 4434.00M
Issuance of capital stock 89.00M 101.00M 116.00M 163.00M 220.00M
Depreciation 729.00M 636.00M 635.00M 608.00M 760.00M
Other cashflows from investing activities -101.00M -351.00M -416.00M -152.00M 299.00M
Dividends paid 381.00M 345.00M 314.00M -292.00M -277.00M
Change to inventory -1082.00M -2270.00M -1294.00M -1259.00M -1169.00M
Change to account receivables -1999.00M -3935.00M -2954.00M -1082.00M -1843.00M
Sale purchase of stock -4750.00M -3146.00M -3025.00M -3638.00M -3516.00M
Other cashflows from financing activities -372.00M -554.00M -175.00M 9123.00M 10092.00M
Change to netincome - - - 140.00M 2064.00M
Capital expenditures 745.00M 859.00M 687.00M 558.00M 535.00M
Change receivables - - - -1082.00M -1843.00M
Cash flows other operating - - - -1121.00M 290.00M
Cash and cash equivalents changes - - - 249.00M -1976.00M
Change in working capital 162.00M 1155.00M -64.00M 384.00M 82.00M
Stock based compensation - - 182.00M - -
Other non cash items 272.00M 923.00M 1186.00M 465.00M 2271.00M
Free cash flow 5410.00M 5226.00M 3627.00M 4601.00M 3899.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MCK
McKesson Corporation
35.22
3.52%
1034.84 24.45 20.41 0.26 5.04 0.27 15.03
COR
Cencora Inc.
13.60
3.99%
354.10 24.22 16.39 0.19 20.41 0.21 13.72
CAH
Cardinal Health Inc
5.53
2.18%
258.46 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc
-
-%
88.24 25.89 15.08 0.72 3.14 1.00 13.43
SHTDY
SINOPHARM GROUP CO LTD ADR
-
-%
10.58 6.18 7.49 0.01 0.76 0.03 0.72

Profile*

McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

6555 State Highway 161, Irving, TX, United States, 75039

972 446 4800

41600

Name Title Year Born
Mr. Brian S. Tyler Ph.D. CEO & Director 1967
Mr. Britt J. Vitalone Exec. VP & CFO 1969
Ms. Nancy Avila Exec. VP, Chief Information Officer & CTO 1967
Ms. Lori A. Schechter J.D. Exec. VP, Chief Legal Officer & Gen. Counsel 1962
Mr. Napoleon B. Rutledge Jr. Sr. VP, Controller & Chief Accounting Officer 1972
Ms. Holly Weiss Sr. VP of Investor Relations NA
Mr. Pete Slone Sr. VP of Corp. Public Affairs NA
Ms. LeAnn B. Smith Exec. VP & Chief HR Officer NA
Mr. Kirk Kaminsky Pres of The US Pharmaceutical & Specialty Solutions Bus. NA
Paul A. Smith Sr. VP of Taxes NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…